Sanfilippo syndrome type A: early cardiac involvement of two patients with cardiac manifestations

Cardiovasc Pathol. 2022 Sep-Oct:60:107430. doi: 10.1016/j.carpath.2022.107430. Epub 2022 May 7.

Abstract

Purpose: To report two unusual presentations of mucopolysaccharidosis type III (Sanfilippo syndrome) and provide evidence for the cardiac involvement.

Patients and methods: We report two siblings with cardiac involvement that were diagnosed in childhood with Sanfilippo A Syndrome (SAS). All patients' diagnosis was confirmed by the excess of heparan sulfate in the urine and the reduction of heparan sulfamidase protein activity. The heart specimens were studied.

Results: We report two sibling patients (15-years-old female and 12-years-old female) occurring in sisters both with onset in childhood with no neurological, ophthalmic, hepatic symptoms or coarsening of features as classically described. Both patients underwent bilateral hip arthroplasty in their early 30`s. The older sister had an orthotopic heart transplant because of end-stage heart failure of her cardiomyopathy at the age of 45. She is alive and well. The youngest sister died due to heart failure before a transplantation took place. In the two siblings a thin right ventricular free wall was seen, which triggered the differential diagnosis with arrhythmogenic right ventricular cardiomyopathy or lamin A/C cardiomyopathy.

Conclusions: Early recognition of solitary or mainly cardiac involvement is essential for patients with mucopolysaccharidosis type III (SAS).

Keywords: Autopsy; Heart; Mucopolysaccharidosis type III; Sanfilippo syndrome; Transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Cardiomyopathies*
  • Female
  • Heart Failure* / etiology
  • Heparitin Sulfate / metabolism
  • Humans
  • Lamin Type A
  • Mucopolysaccharidosis III* / complications
  • Mucopolysaccharidosis III* / metabolism
  • Mucopolysaccharidosis III* / pathology

Substances

  • Lamin Type A
  • Heparitin Sulfate